The field of Glycobiology focuses on the structure, biosynthesis, and biology of saccharides, a group of carbohydrates found in plants, animals, and bacteria. Glycobiology also studies the evolution of a variety of sugars and metabolites that are found throughout nature.
Glycoproteins play an important role in the development of drugs, which is why a deep understanding of glycosylation is so important. As the study of glycosylation continues to expand, it should provide a solid foundation for industrial research jobs. The chemistry of sugars is the basis for many medicines and biotechnology products.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
The vast majority of naturally occurring biological macromolecules are composed of monosaccharides, with many of them containing only a small number of monosaccharide units. Even though they are found in animals and plants, most of their glycans have not yet been discovered or structurally defined. Therefore, a tremendous diversity of glycans may still exist in nature.
The growing number of product launches such as mass spectrometry devices, high profile liquid chromatography (HPLC) devices, and others is projected to drive the global glycobiology market growth. For instance, in May 2019, Shimadzu Corporation announced the launch of Novel Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer, which provides fast, high-sensitive measurements through an ultra-compact design for clinical and laboratory research.
Global Glycobiology Market– Impact of Coronavirus (COVID-19) Pandemic
Supply chain and manufacturing activities in India, Italy, Spain, the U.K., and the U.S. have been disrupted due to lockdowns implemented by various governments in the past few months, while countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drug products. The coronavirus or COVID-19 outbreak that started from Wuhan, China, has spread across continents, affecting various industries globally. Supply of key materials has been severely disrupted due to forced quarantine and lack of labor and raw materials. As the supply link between regional warehouses is not smooth, the transportation of raw materials between various regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain of the global glycobiology market. The COVID-19 pandemic has impacted the global economy and in turn, the glycobiology market.
Moreover, rise in research and development related to oligosaccharides is also expected to aid in growth of the global glycobiology market over the forecast period. For instance, in July 2022, Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, announced the launch of its novel product Glysite™ Scout Glycan Screening Kits. These immunofluorescence (IF) kits are fully integrated for the detection of glycan expression in tissue sections and will support the ability to profile and characterize complex glycans in biological systems.
Request PDF Brochure with Latest Insights @
Key Takeaways of the Global Glycobiology Market:
The global glycobiology market is expected to exhibit a CAGR of 12.8% during the forecast period owing to the increasing focus on production anti-cancer drugs, this is projected to boost growth of the market. For instance, in January 2020, researchers from Universidade do Porto, Portugal, assessed the role of O-glycosylation using glycoengineered gastric cancer models in the detection of CD44v9 – a major protein splice variant isoforms expressed in human gastrointestinal cancer cells—using monoclonal antibodies.
Among Applications, Drug discovery and development segment is accounted for the largest market share in global glycobiology market in 2020. Additionally, investments on drug discovery and development by the key players involved in the market is projected to drive the segment growth over the forecast period. For instance, Merck invested around US$ 9,872 million and US$ 9,752 million on research and development in 2019 and 2018, respectively.
Among the regions, Asia Pacific is projected to exhibit higher CAGR in the global glycobiology market over the forecast period. For instance, in June 2019, a group of Japanese scientists from different universities and research institutes discovered a novel SGL enzyme ((TfSGLr) from a soil fungus, Talaromyces funiculosus. This enzyme TfSGL protein (TfSGLr) was found to break down both linear and cyclic β-1,2-glucans for carbohydrate metabolism.
Key players involved in the global glycobiology market are Merck & Co., Inc., Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, Plexera LLC, New England Biolabs, and Agilent Technologies, Inc.
Reasons to buy this Glycobiology Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Glycobiology Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Glycobiology Market
◘ Leading company profiles reveal details of key Glycobiology Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging Glycobiology Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Glycobiology Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Glycobiology Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Glycobiology Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Glycobiology Industry Impact
Chapter 2 Global Glycobiology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Glycobiology (Volume and Value) by Type
2.3 Global Glycobiology (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Glycobiology Sales, Consumption, Export, Import by Regions
Chapter 5 North America Glycobiology Market Analysis
Chapter 6 East Asia Glycobiology Market Analysis
Chapter 7 Europe Glycobiology Market Analysis
Chapter 8 South Asia Glycobiology Market Analysis
Chapter 9 Southeast Asia Glycobiology Market Analysis
Chapter 10 Middle East Glycobiology Market Analysis
Chapter 11 Africa Glycobiology Market Analysis
Chapter 12 Oceania Glycobiology Market Analysis
Chapter 13 South America Glycobiology Market Analysis
Chapter 14 Company Profiles and Key Figures in Glycobiology Business
Chapter 15 Global Glycobiology Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027